| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |